Cargando…
Ex vivo manipulation of bone marrow cells to rescue uremia-induced dysfunction for autologous therapy
Uremic toxins are known to affect the regenerative properties of tissue-resident and circulating stem cells and thus appear to be a limiting factor for autologous stem cell-based approaches for treating chronic kidney disease. The recent article by van Koppen and colleagues in Stem Cell Research &am...
Autores principales: | Grange, Cristina, Bussolati, Benedetta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462013/ https://www.ncbi.nlm.nih.gov/pubmed/26062806 http://dx.doi.org/10.1186/s13287-015-0108-z |
Ejemplares similares
-
Indoxyl sulfate in uremia: an old idea with updated concepts
por: Berg, Anders H., et al.
Publicado: (2022) -
Immune Dysfunction in Uremia—An Update
por: Cohen, Gerald, et al.
Publicado: (2012) -
Immune Dysfunction in Uremia 2020
por: Cohen, Gerald
Publicado: (2020) -
Special Issue: Immune Dysfunction in Uremia
por: Cohen, Gerald, et al.
Publicado: (2021) -
Long-term efficacy of autologous bone marrow mesenchymal stromal cells for treatment of knee osteoarthritis
por: Lamo-Espinosa, José María, et al.
Publicado: (2021)